Cargando…

Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system

α-Synuclein and tau are abundant multifunctional brain proteins that are mainly expressed in the presynaptic and axonal compartments of neurons, respectively. Previous works have revealed that intracellular deposition of α-synuclein and/or tau causes many neurodegenerative disorders, including Alzhe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Mingyue, Wang, Shengming, Gao, Xiaodie, Zou, Zhenyou, Hirotsune, Shinji, Sun, Liyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664117/ https://www.ncbi.nlm.nih.gov/pubmed/37843221 http://dx.doi.org/10.4103/1673-5374.382231

Ejemplares similares

α-Synuclein in traumatic and vascular diseases of the central nervous system
por: Zeng, Hong, et al.
Publicado: (2020)

α-Synuclein serine129 phosphorylation – the physiology of pathology
por: Ramalingam, Nagendran, et al.
Publicado: (2023)

Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology
por: Jorge-Oliva, Marta, et al.
Publicado: (2022)

DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers
por: Jin, Mingyue, et al.
Publicado: (2022)

Autophagy in the physiology and pathology of the central nervous system
por: Nikoletopoulou, V, et al.
Publicado: (2015)

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
por: Thomzig, Achim, et al.
Publicado: (2014)

Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
por: Pace, Michael C., et al.
Publicado: (2018)

Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
por: Jiang, Yixiang, et al.
Publicado: (2023)

Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System
por: Nutma, Erik, et al.
Publicado: (2020)

The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
por: Miquel-Rio, Lluis, et al.
Publicado: (2023)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Macdonald, Jennifer A., et al.
Publicado: (2021)

ADAMTS proteoglycanases in the physiological and pathological central nervous system
por: Lemarchant, Sighild, et al.
Publicado: (2013)

Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism
por: Taymans, Jean-Marc, et al.
Publicado: (2014)

Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization
por: Calogero, Alessandra Maria, et al.
Publicado: (2023)

α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications
por: Li, Amanda, et al.
Publicado: (2022)

The Role of α-Synuclein and LRRK2 in Tau Phosphorylation
por: Kawakami, Fumitaka, et al.
Publicado: (2015)

α-Synuclein modulates tau spreading in mouse brains
por: Bassil, Fares, et al.
Publicado: (2020)

Neuronal identity defines α-synuclein and tau toxicity
por: Praschberger, Roman, et al.
Publicado: (2023)

Base Excision Repair in Physiology and Pathology of the Central Nervous System
por: Bosshard, Matthias, et al.
Publicado: (2012)

A Course of Lectures on the Physiology and Pathology of the Central Nervous System
Publicado: (1862)

Microglia/macrophage diversities in central nervous system physiology and pathology
por: Xie, Di, et al.
Publicado: (2019)

Roles of Ependymal Cells in the Physiology and Pathology of the Central Nervous System
por: Deng, Shiyu, et al.
Publicado: (2023)

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
por: Mollenhauer, Brit, et al.
Publicado: (2012)

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease
por: Zhou, Lan-Ting, et al.
Publicado: (2023)

Cross-talks between the kidneys and the central nervous system in multiple sclerosis
por: Rostami, Sahar, et al.
Publicado: (2018)

SUMOylation in α-Synuclein Homeostasis and Pathology
por: Savyon, Mor, et al.
Publicado: (2020)

Initiation and propagation of α-synuclein aggregation in the nervous system
por: Hijaz, Baraa A., et al.
Publicado: (2020)

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
por: Sacino, Amanda N, et al.
Publicado: (2013)

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau
por: Hudák, Anett, et al.
Publicado: (2019)

Templated α-Synuclein Inclusion Formation Is Independent of Endogenous Tau
por: Stoyka, Lindsay E., et al.
Publicado: (2021)

S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System
por: D’Ambrosi, Nadia, et al.
Publicado: (2021)

Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk
por: Kayed, Rakez, et al.
Publicado: (2020)

The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
por: Battis, Kristina, et al.
Publicado: (2023)

Physiology and Pathology of the Nervous System
por: Brown-Sequard,
Publicado: (1859)

The distribution of tau in the mammalian central nervous system
Publicado: (1985)

Propagation of pathological α-synuclein in marmoset brain
por: Shimozawa, Aki, et al.
Publicado: (2017)

Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy
por: Williams, Tosha, et al.
Publicado: (2020)

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
por: Badiola, Nahuai, et al.
Publicado: (2011)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0ath910955qn77nhnjc3habf8a